Barclays (LON:BARC) initiated coverage on Natera shares (NASDAQ:NTRA), currently trading at $171.93, with an Overweight rating and a $200 price target. The stock has demonstrated remarkable momentum, ...

Barclays (LON:BARC) initiated coverage on Exact Sciences (NASDAQ:EXAS), a leading molecular diagnostics company with a market capitalization of $10.14 billion, assigning the stock an Overweight rating ...

Barclays (LON:BARC) began coverage on Guardant Health (NASDAQ:GH) shares, assigning an Overweight rating and setting a price target of $60. The new outlook comes as Guardant Health, a precision ...

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where Arm ...

In a report released today, Raimo Lenschow from Barclays maintained a Buy rating on Sprout Social (SPT – Research Report), with a price target ...

Barclays (LON:BARC) analyst Nicholas Campanella revised the price target for Edison International (NYSE:EIX) shares, reducing ...

Barclays analyst Jared Shaw maintained a Buy rating on Wintrust Financial (WTFC – Research Report) today and set a price target of $155.00. The ...

Barclays (LON:BARC) reaffirmed its positive stance on Replimune Group (NASDAQ:REPL), maintaining an Overweight rating and a $17.00 price target, representing significant upside from the current price ...

In a report released today, Betty Jiang from Barclays maintained a Hold rating on APA (APA – Research Report), with a price target of $27.00.

The Nasdaq led gains among Wall Street's main indexes on Wednesday, as investors cheered streaming giant Netflix's strong ...

We recently compiled a list of the 10 AI News You Probably Missed. In this article, we are going to take a look at where ...